Alumis shares fall nearly 16% in Nasdaq debut-March 2024-www.financetom.com

Alumis shares fall nearly 16% in Nasdaq debut

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Alumis shares fall nearly 16% in Nasdaq debut

Jun 28, 2024 9:59 AM

June 28 (Reuters) - Shares of biopharmaceutical firm

Alumis opened nearly 16% below their initial public

offering (IPO) price in their debut on the Nasdaq on Friday.

Previous page： Blink Charging Q4 Earnings: Revenue and EPS Beat, Strong FY24 Outlook and More Next page： Looking At Amgen's Recent Unusual Options Activity

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Blink Charging Q4 Earnings: Revenue and EPS Beat, Strong FY24 Outlook and More

Mar 14, 2024

Blink Charging Co. ( BLNK ) reported its fourth-quarter financial results after the bell Thursday. Here's a look at the highlights. Blink reported quarterly losses of 28 cents per share, which beat the analyst consensus estimate of losses of 31 cents and represented a 31.71% increase year-over-year. The company clocked fourth-quarter sales of $42.71 million, beating the analyst consensus estimate of $35.64...

Looking At Amgen's Recent Unusual Options Activity

Mar 14, 2024

Financial giants have made a conspicuous bearish move on Amgen ( AMGN ). Our analysis of options history for Amgen ( AMGN ) revealed 11 unusual trades. Delving into the details, we found 36% of traders were bullish, while 63% showed bearish tendencies. Out of all the trades we spotted, 9 were puts, with a value of $445,336, and 2...

Allogene Therapeutics Q4 Loss Narrows, Revenue Drops

Mar 14, 2024

04:31 PM EDT, 03/14/2024 (MT Newswires) -- Allogene Therapeutics ( ALLO ) reported late Thursday a Q4 net loss of $0.51 per diluted share, narrowing from $0.67 a year ago. Analysts polled by Capital IQ expected a loss of $0.45. Collaboration revenue for the quarter ended Dec. 31 was $21,000, compared with $26,000 a year earlier. Analysts surveyed by Capital...

EverCommerce Q4 Loss Widens, Revenue Rises; Q1, 2024 Revenue Outlook Set; Shares Drop After Hours

Mar 14, 2024

04:28 PM EDT, 03/14/2024 (MT Newswires) -- EverCommerce ( EVCM ) reported a Q4 loss late Thursday of $0.12 per diluted share, widening from the loss of $0.09 a year earlier. Analysts polled by Capital IQ expected a loss of $0.02. Revenue in the quarter ended Dec. 31 rose to $169.4 million from $161.8 million a year earlier. Analysts surveyed...